Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CNXUConexeu Sciences Inc.

Nasdaq · CIK 0002066836
Filer category<br>Emerging growth company
Entity typeoperating
SIC3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
FY end1031
XBRL facts123

Identity from submissions API

NameConexeu Sciences Inc.
CIK0002066836
TickersCNXU
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
EIN000000000
LEI—
Fiscal year end1031
State of incorporationNV NV
Phone604-315-4722
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
50 WEST LIBERTY STREET, SUITE 880
RENO
NV
89501
NV
Mailing address
50 WEST LIBERTY STREET, SUITE 880
RENO
NV
89501
NV

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

92 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 S-1 FORM S-1 0001062993-26-006205 333-300165 261575367 33 2312292 1 1
2026-11-16 8-K FORM 8-K 8.01,9.01 0001062993-26-006086 001-43283 261561738 34 233686 1 1
2026-11-05 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000066 021-603800 261526642 33 14769
2026-11-05 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000065 021-603797 261526608 33 14771
2026-10-29 424B3 FORM 424B3 0001062993-26-005604 333-291845 261502315 33 29359
2026-10-27 8-K FORM 8-K 3.02,8.01,9.01 0001062993-26-005569 001-43283 261490964 34 806846 1 1
2026-10-21 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000061 021-601951 261474013 33 14941
2026-10-21 424B3 FORM 424B3 0001062993-26-005440 333-291845 261473891 33 27621
2026-10-20 8-K FORM 8-K 3.02,9.01 0001062993-26-005431 001-43283 261473071 34 237252 1 1
2026-10-19 4 PRIMARY DOCUMENT 0002128469-26-000009 7529
2026-09-29 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000059 021-599248 261423256 33 14771
2026-09-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-005090 8389
2026-09-15 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001062993-26-004967 005-95809 261381827 34 15091
2026-09-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-004966 7783
2026-09-15 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000058 021-597545 261380468 33 14829
2026-09-15 424B3 FORM 424B3 0001062993-26-004940 333-291845 261378659 33 688505
2026-09-14 10-Q FORM 10-Q 0001062993-26-004935 001-43283 261377742 34 8785059 1 1
2026-09-10 424B3 FORM 424B3 0001062993-26-004894 333-291845 261371969 33 30481
2026-09-10 8-K FORM 8-K 3.02,9.01 0001062993-26-004891 001-43283 261371486 34 235770 1 1
2026-09-09 4/A PRIMARY DOCUMENT 0002128469-26-000008 9289
2026-09-09 4 PRIMARY DOCUMENT 0002128469-26-000007 8807
2026-09-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000912282-26-001228 005-95809 261361143 34 7460
2026-09-04 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000912282-26-001226 005-95809 261360994 34 7413
2026-08-31 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000053 021-595920 261344910 33 14877
2026-08-18 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001062993-26-004475 005-95809 261288353 34 15730
2026-08-18 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001062993-26-004473 005-95809 261288346 34 6811
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002128469-26-000006 005-95809 261282700 34 206582
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002080821-26-000002 005-95809 261282398 34 6240
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002080820-26-000003 005-95809 261282312 34 6562
2026-07-31 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000048 021-592754 261224960 33 14761
2026-07-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002137182-26-000004 005-95809 261209996 34 6964
2026-07-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000912282-26-000991 005-95809 261185923 34 6517
2026-07-07 8-K FORM 8-K 7.01,9.01 0001062993-26-003545 001-43283 261160106 34 274095 1 1
2026-06-30 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000039 021-589046 261137449 33 14762
2026-06-30 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000038 021-589044 261137442 33 14967
2026-06-29 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-003389 4347
2026-06-24 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-003332 4332
2026-06-23 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-003323 4357
2026-06-23 4 PRIMARY DOCUMENT 0002128469-26-000005 9201
2026-06-22 4 PRIMARY DOCUMENT 0002137182-26-000003 7873
2026-06-16 424B3 FORM 424B3 0001062993-26-003216 333-291845 261092642 33 711653
2026-06-15 10-Q FORM 10-Q 0001062993-26-003207 001-43283 261091277 34 7402339 1 1
2026-06-12 D/A xslFormDX01/primary_doc.xml 06b 0002060755-26-000034 021-548921 261086060 33 12709
2026-06-10 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000033 021-586895 261079432 33 12508
2026-06-09 8-K FORM 8-K 3.02,9.01 0001062993-26-003128 001-43283 261076559 34 230625 1 1
2026-05-28 4 PRIMARY DOCUMENT 0002137182-26-000002 8197
2026-05-27 3 PRIMARY DOCUMENT 0002137182-26-000001 9162
2026-05-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002870 7918
2026-05-21 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000028 021-584843 261009884 33 12356
2026-05-21 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000027 021-584842 261009839 33 12584
2026-05-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002732 4811
2026-05-15 424B3 FORM 424B3 0001062993-26-002716 333-291845 26989797 33 31820
2026-05-15 8-K FORM 8-K 3.02,5.03,9.01 0001062993-26-002703 001-43283 26988100 34 403155 1 1
2026-05-15 424B3 FORM 424B3 0001062993-26-002661 333-291845 26981597 33 832299
2026-05-14 4 PRIMARY DOCUMENT 0002080820-26-000002 9040
2026-05-14 4 PRIMARY DOCUMENT 0002128469-26-000004 9202
2026-05-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001569 333-291845 26965523 33 1774
2026-05-11 3 PRIMARY DOCUMENT 0002080821-26-000001 3899
2026-05-11 3 PRIMARY DOCUMENT 0002080820-26-000001 4918
2026-05-11 3 PRIMARY DOCUMENT 0002128469-26-000003 5598
2026-05-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002494 7867
2026-05-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002490 4017
2026-05-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002488 5413
2026-05-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002486 3661
2026-05-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002484 4854
2026-05-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002482 5640
2026-05-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002480 5167
2026-05-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-26-002479 4415
2026-05-11 424B4 FORM 424B4 0001062993-26-002473 333-291845 26964542 33 2480630
2026-05-11 CERT CNXU_8A_Cert_0002066836.pdf 0001354457-26-000435 001-43283 26964048 34 114821
2026-05-11 8-A12B FORM 8-A12B 0001062993-26-002453 001-43283 26961413 34 11917
2026-04-17 S-1/A FORM S-1/A 0001062993-26-002041 333-291845 26871103 33 2622481
2026-04-10 S-1/A FORM S-1/A 0001062993-26-001914 333-291845 26852856 33 2622544
2026-04-06 S-1/A FORM S-1/A 0001062993-26-001871 333-291845 26842039 33 2614414
2026-04-01 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000022 021-578656 26824122 33 12338
2026-03-26 S-1/A FORM S-1/A 0001062993-26-001640 333-291845 26797629 33 2613250
2026-03-23 D xslFormDX01/primary_doc.xml 06b 0001062993-26-001563 021-577255 26779567 33 12333
2026-03-05 S-1/A FORM S-1/A 0001062993-26-001297 333-291845 26723960 33 2486218 1 1
2026-03-02 C-AR xslC_X01/primary_doc.xml 0001062993-26-001214 020-36215 26703047 33 12337835
2026-02-27 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000015 021-574901 26691534 33 12597
2026-02-04 D xslFormDX01/primary_doc.xml 06b 0002060755-26-000011 021-572364 26597547 33 12328
2026-02-03 S-1/A FORM S-1/A 0001062993-26-000578 333-291845 26594672 33 2807314 1 1
2025-11-28 S-1 FORM S-1 0001062993-25-017070 333-291845 251535691 33 7991893 1 1
2025-11-20 D xslFormDX01/primary_doc.xml 06b 0002060755-25-000059 021-564600 251502730 33 12194
2025-11-13 D xslFormDX01/primary_doc.xml 06b 0002060755-25-000054 021-563829 251474931 33 12235
2025-10-14 C-U xslC_X01/primary_doc.xml 0001062993-25-016029 020-36215 251389032 33 10894
2025-09-23 C-U xslC_X01/primary_doc.xml 0001062993-25-015759 020-36215 251333508 33 10886
2025-07-30 C/A xslC_X01/primary_doc.xml 0001062993-25-013287 020-36215 251166680 33 29465098
2025-07-30 C xslC_X01/primary_doc.xml 0001062993-25-013275 020-36215 251165268 33 29464857
2025-07-02 D/A xslFormDX01/primary_doc.xml 06b 0002060755-25-000024 021-545611 251100208 33 11067
2025-06-13 D xslFormDX01/primary_doc.xml 06b 0002060755-25-000021 021-548921 251045713 33 10886
2025-05-09 D xslFormDX01/primary_doc.xml 06b 0001062993-25-008936 021-545611 25927921 33 9341

Latest XBRL company facts

One latest value per concept from companyfacts (123 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 28.21M 2026-09-10 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
ffd NetFeeAmt NetFeeAmt USD 1,466.78 2026-11-18 S-1 2026-11-19 0001062993-26-006205
ffd TtlFeeAmt TtlFeeAmt USD 1,466.78 2026-11-18 S-1 2026-11-19 0001062993-26-006205
ffd TtlOfferingAmt TtlOfferingAmt USD 16.86M 2026-11-18 S-1 2026-11-19 0001062993-26-006205
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-18 S-1 2026-11-19 0001062993-26-006205
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-18 S-1 2026-11-19 0001062993-26-006205
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 784,158 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 16,195 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 22.09M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap AdjustmentForAmortization Amortization USD 12,888 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.49M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 482,177 2024-11-01 2025-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap AdvertisingExpense Advertising Expense USD 126,665 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap Assets Assets USD 7.16M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap AssetsCurrent Assets, Current USD 6.76M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap BusinessDevelopment Business Development USD 1.41M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap Cash Cash USD 290,718 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.97M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 2.21M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -2.63M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2.47M 2025-11-01 2026-04-30 2026 Q2 10-Q 2026-06-15 0001062993-26-003207
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 75,905 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 1.68M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 909,868 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 2.3 2026-04-30 2026 Q2 10-Q 2026-06-15 0001062993-26-003207
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 27.40M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 27.40M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap CommonStockValue Common Stock, Value, Issued USD 27,397 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap Depreciation Depreciation USD 10,408 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 23,296 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.52 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.52 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 2,997 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 0 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 22,707 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 163,996 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -13,688 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -2,740 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 58,490 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap GeneralInsuranceExpense General Insurance Expense USD 172,857 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -11.75M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 0 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 524,865 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 2,426 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 45,374 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -76,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -3,037 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -9,000 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 3.52M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD -18,475 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap InterestExpense Interest Expense USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 2,426 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 129,800 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap Investments Investments USD 71,328 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap LeaseCost Lease, Cost USD 10,378 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 74,777 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 22,433 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 41,127 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 11,217 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2,295 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap Liabilities Liabilities USD 1.31M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 7.16M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.27M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ManagementAndIncentiveFeesExpense ManagementAndIncentiveFeesExpense USD 2.85M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 126,665 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 7.55M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -76,231 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -10.10M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -11.75M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 0 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingExpenses Operating Expenses USD 11.79M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -11.79M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingLeaseCost Operating Lease, Cost USD 10,378 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 72,482 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 39,249 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 33,233 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingLeasePayments Operating Lease, Payments USD 7,478 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 71,641 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.038 2026-05-01 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 45,374 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 42,943 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PaymentsForDeposits Payments for Deposits USD 18,475 2026-05-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PaymentsForProceedsFromLoansReceivable Payments for (Proceeds from) Loans Receivable USD 2 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PaymentsToAcquireLoansReceivable Payments to Acquire Loans Receivable USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 76,229 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 4.54M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.72M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 2.94M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5,526 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1,750 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ProfessionalFees Professional Fees USD 809,307 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 90,513 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 74,318 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 399,578 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap RestrictedCash Restricted Cash USD 238,208 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 238,208 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -16.27M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap SecurityDeposit Security Deposit USD 18,475 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.49M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 5.85M 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap StockIssued1 Stock Issued USD 0 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 207,594 2024-11-30 2025-01-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 122,898 2024-11-01 2025-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 3.08M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.94M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 2.72M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 22.73M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 22.73M 2025-11-01 2026-07-31 2026 Q3 10-Q 2026-09-14 0001062993-26-004935

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →